Drug intelligence / Profile preview

Tl-3-093

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

Tl‑3‑093 is an experimental small molecule dipeptide derivative with the chemical formula C25H33N3O5 and a molecular weight of approximately 455.5 g/mol. It is classified as a dipeptide, specifically N-benzoxycarbonyl-L-alanyl-L-valyl-L‑phenylalaninol (Cbz-Ala-Val-Pheol). The compound has been studied in medicinal chemistry and drug discovery, but there are no approved indications or advanced clinical trials reported for this agent. Its precise mechanism of action and therapeutic target have not been publicly disclosed[1][3][2].

Other names
benzyl N-[(1S)-1-{[(1S)-1-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}ethyl]carbamatebenzyl N-((1S)-1-(((1S)-1-(((2S)-1-hydroxy-3-phenylpropan-2 yl)carbamoyl)-2-methylpropyl)carbamoyl)ethyl)carbamateCbz-Ala-Val-Phe-alcohol (Cbz-Ala-Val-Pheol)

Beyond the preview

Go deeper on Tl-3-093.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tl-3-093.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call